Authors
Loading...
Preclinical study reveals that monoallelic TP53 mutations trigger chromosomal instability while biallelic loss drives self-renewal in human HSPCs, highlighting early intervention targets.
Lind et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: